Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2023 –2030 | |
|
|
USD 390.95 Million |
| USD 600.00 Million | |
| % | |
|
Global Buergear’s Disease Treatment Market, By Diagnosis Type (Blood Test, Allens’ Test, Angiogram, Tissue Biopsy and Others), Treatment (Medication, Surgery and Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) – Industry Trends and Forecast to 2030.
Developing economies are major markets for Buerger’s disease treatment because of the expansion of healthcare infrastructure in these economies. Major market players operating in the market are focused on expansion of their product portfolios by emerging new products with reduced side-effects and enhanced effectiveness to treat Buerger’s disease. Economic development, increased disposable income of patients, and healthcare awareness in Asia and Latin America are slowly attracting major players to expand their business in these regions.
Data Bridge Market Research analyses a growth rate in the buerger’s disease treatment market in the forecast period 2023-2030. The expected CAGR of buerger’s disease treatment market is tend to be around 5.50% in the mentioned forecast period. The market was valued at USD 390.95 million in 2022, and it would grow upto USD 600 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Diagnosis Type (Blood Test, Allens’ Test, Angiogram, Tissue Biopsy and Others), Treatment (Medication, Surgery and Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
FUJIFILM Holdings Corporation (Japan), General Electric (US), Koninklijke Philips N.V. (Netherlands), Pluristem Inc. (Israel), Shimadzu Corporation (Japan), Siemens Healthcare GmbH (Germany), STEMPEUTICS RESEARCH PVT LTD. (India), Toshiba Medical Corporation (Japan), t2cure GmbH (Germany)
|
|
Market Opportunities
|
|
Market Definition
Buerger’s disease is a genetic condition which often affects young or middle-aged male smokers. This is typically characterized by narrowing or obstruction of the extremities' veins and arteries, that leads to a decreased blood supply to these areas as peripheral vascular disease. The exact causes of this disease are not really known but tobacco is believed to be responsible to an extent, in the development of this disease. Some major symptoms of this disease are pain in feet and arms, inflammation, Raynaud's phenomenon and such. There is no 100% cure for this disease.
Drivers
Tobacco abuse treatment providers and manufacturers of treatment products are primarily focused on the creation of awareness among people and drug store owners about the severe effects of tobacco in order to expand their customer pool. For instance, cigarette smoking is a major cause of Buerger’s disease. Increasing awareness about these health hazards has prompted patients to choose smoking cessation therapy. Additionally. smoking cessation campaigns have also proved to be a major driver of the global buerger’s disease treatment market.
All contributing factors are the advances in advanced biologics, increased purchasing power, increased healthcare expenditure, and worldwide access to high-quality medications for middle- and poor-class families. On the other hand, the global buerger’s disease treatment market is predicted to increase quickly because of the enhanced treatment regarding early treatment and screening of buerger’s disease treatment and shift the market outlook. Consequently, growing advancements in biologics is creating huge opportunities for the growth of global buerger’s disease treatment market.
Opportunities
There are varied diagnostic tests that are helping in increasing the growth of the market. Several tests such as Allen’s test, angiogram, tissue biopsy are contributing for the same. Rise in the number of blood tests for the diagnosis of Buerger’s disease is anticipated to expand the market growth. Furthermore, blood test is the primary test that a physician suggest to rule out the Buerger’s disease. This creates much opportunities for the market growth.
Approvals for new treatments or therapies plays a major role in the growth of this market. For instance, in 2016, the Indian company named STEMPEUTICS RESEARCH PVT LTD got limited approval from the Drugs Controller General (India) for commercialization of stem cell based biological product Stempeucel for the treatment of Buerger's Disease. Additionally, Germany based company named t2cure GmbH also initiated a pivotal clinical study for Buerger's disease. Thus, all these factors create much opportunities for the market growth.
Restraints/Challenges
The lack of qualified healthcare professionals who are unable to perform the treatments could reduce the growth of the buerger’s disease treatment market over a forecast period.
Low awareness about addiction treatment products as well as awareness programs in developing countries is projected to restrain the market during the forecast period.
This buerger’s disease treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the buerger’s disease treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
The buerger’s disease treatment market is segmented on the basis of diagnosis type, treatment, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Diagnosis Type
Treatment
End-Users
Distribution Channel
The buerger’s disease treatment market is analyzed and market size insights and trends are provided by diagnosis, treatment, end-user and distribution channel as referenced above.
The major countries covered in the buerger’s disease treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the market due to the availability of funding for research and clinical trials.
Asia-Pacific is expected to account for the largest market share due to several significant factors such as the expansion of healthcare facilities and government support to enhance public health in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
The buerger’s disease treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to buerger’s disease treatment market
Key players operating in the buerger’s disease treatment market include:
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.